Inhibition of NIK using a NIK-specific small molecule inhibitor (NIK SMI1) increased survival in an experimental murine models of lupus by restricting overactive immune cells through a reduction in OX40, BAFF, and CD40 signaling [40]. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.